Current stem cell research from biomedicine databases and scientific journals
Stemodontics is at the forefront of innovative clinical applications leading to better treatments and therapies for patients. Discover what researchers are working on today in their mission to expand the applied uses for these remarkable cells.
Latest research
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
Exosomes, small particles made by bone marrow mesenchymal stem cells, may be useful in treating ovarian failure induced by cancer therapy.
READ
Dental pulp stem cell-based therapies may be beneficial in the treatment of pediatric diseases, including chronic liver fibrosis and hemophilia A.
READ
This study examines how MSCs can be used to treat stroke and suggests that aggregating the cells before using them could be helpful.
READ
This paper shows how modulating the materials (hydrogels) that are used to grow MSCs can impact what the cells become. This may be useful for making specific cell types, in order to make bone or cartilage.
READ
Cortical bone stem cells (CBSCs) were shown to alter cell death after cardiac reperfusion injury, suggesting a mechanism by which these cells could help patients after myocardial infarction (heart attack).
READ
In this study of treatment of facial paralysis, a single injection of human immature DPSCs promoted a positive effect on the regeneration of the facial nerve trunk.
READ
In this study of treatment of facial paralysis, a single injection of human immature DPSCs promoted a positive effect on the regeneration of the facial nerve trunk.
READ
Cortical bone stem cells (CBSCs) were shown to alter cell death after cardiac reperfusion injury, suggesting a mechanism by which these cells could help patients after myocardial infarction (heart attack).
READ
This paper studies basic aspects of dental pulp stem cells in mouse incisors and identifies several pathways that are important in their regulation.
READ
This paper found improved scaffolds for mesenchymal stem cells (MSCs) led to better bone regeneration.
READ
This paper studies potential roles for DPSCs in the treatment of Parkinson’s disease.
READ
This paper lays the foundation for use of DPSCs in the treatment of corneal (eye) damage.
READ
Dental pulp stem cells (DPSCs) have the ability to differentiate into neurons for potential use in the treatment of neurological disorders involving a decline in cognitive abilities in humans.
READ
Mesenchymal stem cells (MSCs) show promise as a safe and effective therapeutic agent in the treatment of liver cirrhosis.
READ
Mesenchymal stem cell expression of interleukin-35 protects against ulcerative colitis by suppressing mucosal immune responses.
READ
An allogeneic 'off the shelf' therapeutic strategy for peripheral nerve tissue engineering using clinical grade human neural stem cells
READ
Mesenchymal stem cell-derived exosomes ameliorate erection by reducing oxidative stress damage of corpus cavernosum in a rat model of artery injury.
READ
The dental pulp stem cells (DPSCs) from younger stem cell donors are more effective at tissue repair than those from older donors, providing further evidence of the importance of banking stem cells while young.
READ
In rodents, mesenchymal stem cells (MSCs) applied topically to the brain have the potential to improve neurological function after damage similar to a stroke (cerebral ischemia).
READ
Dental pulp stem cells (DPSCs) may be useful for the treatment of aneurysmal subarachnoid hemorrhage (blood into the subarachnoid space in the brain), which when untreated can lead to neurocognitive impairments and permanent disability.
READ
A dual approach using heart muscle derived from pluripotent stem cells and mesenchymal stem cells (MSCs), was shown to rejuvenate both the muscle cells and vascular systems of the heart and led to a significant improvement of cardiac function and vessel formation after a heart attack.
READ
A study in dogs showed that dental pulp stem cells (DPSCs) may be useful for regenerating dying permanent teeth in younger teeth.
READ
Transplanted blood stem cells (hematopoietic stem cells/HSCs) have been shown to enhance the functional status of patients with systemic sclerosis (a severe chronic disease), significantly improving hand function, physical capacity, and quality of life.
READ
Human dental pulp stem cells (DPSCs) used in new orthopedic approaches for bone repair have better outcomes than methods not using these cells.
READ
New research suggests that mesenchymal stem cells (MSCs) can help in the treatment of inflammatory bowel disease.
READ
Studies indicate that human dental pulp stem cells (DPSCs) could be used in the future to promote skin wound healing by increasing cell proliferation, regulating collagen synthesis and collagen composition, and inducing the formation of new blood vessels (angiogenesis) at the injury site.
READ
Research has shown that transplanted stem cells related to dental pulp stem cells (DPSCs) can be used to aid in recovery from spinal cord injury.
READ
